|
|
|
|
LEADER |
00000pam a2200000 a 4500 |
001 |
3762170 |
003 |
ICU |
005 |
20030527183900.0 |
008 |
960905s1997 paua b 001 0 eng c |
010 |
|
|
|a 96041245
|
020 |
|
|
|a 0397516258
|
035 |
|
|
|a (NhCcYBP)YBT 96041245
|
035 |
|
|
|a (NhCcYBP)YBP99110152453
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
050 |
1 |
0 |
|a RM355
|b .G36 1997
|
060 |
1 |
0 |
|a WI 140 G2595 1996
|
082 |
0 |
0 |
|a 615/.73
|2 20
|
245 |
0 |
0 |
|a Gastrointestinal pharmacology and therapeutics /
|c edited by Gerald Friedman, Eugene D. Jacobson, Richard W. McCallum ; with 87 additional contributors.
|
246 |
1 |
4 |
|a Gastrointestinal pharmacology & therapeutics
|
260 |
|
|
|a Philadelphia :
|b Lippincott-Raven,
|c c1997.
|
300 |
|
|
|a xxii, 780 p. :
|b ill. ;
|c 29 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g 1.
|t Fundamentals of Gastrointestinal Pharmacology /
|r Thomas F. Burks --
|g 2.
|t Helicobacter pylori - Induced Gastritis, Ulceration, and Neoplasia Epidemiology, Pathophysiology, and Therapeutics /
|r Peter Malfertheiner and James Freston --
|g 3.
|t Gastroesophageal Reflux Disease /
|r Peter J. Kahrilis --
|g 4.
|t Gastric and Duodenal Ulcers /
|r Colin W. Howden --
|g 5.
|t Drug-Induced Ulcerogenesis /
|r Naurang M. Agrawal and Esam Z. Dajani --
|g 6.
|t Management of Acid Hypersecretion in Patients with Zollinger-Ellison Syndrome /
|r Paul N. Maton --
|g 7.
|t Stress Ulcer Prophylaxis: A Systematic Review and Evidence-Based Recommendations /
|r Deborah J. Cook --
|g 8.
|t Pathophysiology of Gastrointestinal Motility Disorders /
|r Richard W. McCallum --
|g 9.
|t Principles of Gut Pharmacology /
|r Richard W. McCallum --
|g 10.
|t Pharmacotherapy of the Esophageal Motor Disorders /
|r Ravinder K. Mittal --
|g 11.
|t Therapeutic-Pharmacologic Approach to Delayed Gastric Emptying /
|r Richard W. McCallum --
|g 12.
|t Chronic Intestinal Pseudo-Obstruction /
|r G. Nicholas Verne and Charles S. Sninsky --
|g 13.
|t Pharmacologic Therapy of Irritable Bowel Syndrome /
|r Marvin M. Schuster --
|g 14.
|t Functional Gastrointestinal Disorders Chronic Pain Management /
|r Ivan Barofsky --
|g 15.
|t Gastrointestinal Pain /
|r Charles B. Stacy --
|g 16.
|t The Pathophysiology of Diarrhea and Constipation: The Role of Intestinal Water and Electrolyte Flux /
|r Eugene B. Chang --
|g 17.
|t Cathartics, Laxatives, and Lavage Solutions /
|r Lawrence R. Schiller --
|g 18.
|t Antidiarrheal Therapy /
|r Richard N. Fedorak --
|g 19.
|t Pathophysiology of Gastrointestinal Infections: Host Defenses Versus Microbial Virulence Traits /
|r Nathan M. Thielman and Richard L. Guerrant --
|g 20.
|t Diagnosis and Pharmacotherapy of Infectious Esophagitis /
|r Jonathan P. Moorman --
|g 21.
|t Pharmacology of Small Bowel Infections Pathogens and Therapeutic Approaches /
|r Richard N. Greenberg, Selin Zeytin and Kenneth J. Kortas --
|g 22.
|t Infections of the Colon /
|r Theodore S. Steiner and Richard L. Guerrant --
|g 23.
|t Acquired Immunodeficiency Syndrome and the Gut Pathophysiology /
|r Lee M. Oberman and Donald P. Kotler --
|g 24.
|t Esophageal Disease in Acquired Immunodeficiency Syndrome /
|r Maurizio Bonacini and Loren Laine --
|g 25.
|t The Stomach in Human Immunodeficiency Virus Disease /
|r Gerond Lake-Bakaar --
|g 26.
|t Small Bowel Disease /
|r Ronald Fogel and Tamir Ben-Menachem --
|g 27.
|t Colonic Disease in Acquired Immunodeficiency Syndrome /
|r Michael A. Poles, Douglas T. Dieterich and Edward A. Lew --
|g 28.
|t Agents Commonly Used in the Treatment of Inflammatory Bowel Disease /
|r James H. Reichheld and Mark A. Peppercorn --
|g 29.
|t New Therapeutic Agents /
|r Miguel D. Regueiro and Mark A. Peppercorn --
|g 30.
|t Medical Management of Ulcerative Colitis and Other Colitis Syndromes /
|r Alain Bitton and Mark A. Peppercorn --
|g 31.
|t Medical Management of Crohn's Disease /
|r Alain Bitton and Mark A. Peppercorn --
|g 32.
|t Hepatitis /
|r Gary L. Davis --
|g 33.
|t Pathophysiology and Pharmacology of Cholestasis /
|r Mitchell L. Schiffman and Douglas M. Heuman --
|g 34.
|t Treatment of Chronic Cholestatic Liver Disease /
|r George Dickstein and Marshall M. Kaplan --
|g 35.
|t Pharmacology and Medical Management of Hepatic Cirrhosis and Fibrosis /
|r Bahri M. Bilir and Nuray Bilir --
|g 36.
|t Alcoholic Liver Disease /
|r Charles S. Lieber --
|g 37.
|t Primary Sclerosing Cholangitis Pathogenesis and Therapy /
|r Lee McHenry, Jr., Amy Foxx-Orenstein and Mitchell L. Schiffman --
|g 38.
|t Sphincter of Oddi: Current Approaches /
|r Wahid Y. Wassef and Alvin M. Zfass --
|g 39.
|t Prevention and Medical Treatment of Gallstones /
|r Douglas M. Heuman and Mitchell L. Schiffman --
|g 40.
|t Identification and Management of the Hyperlipidemic Patient /
|r R. T. Stravitz and W. M. Pandak --
|g 41.
|t Pathophysiology of Acute Pancreatitis /
|r Michael L. Steer --
|g 42.
|t Inflammatory Mediators in Acute Pancreatitis /
|r Heinrich Rinderknecht --
|g 43.
|t Treatment of Acute Pancreatitis: From Animal Models to Randomized Human Trials /
|r Scott Tenner and Peter A. Banks --
|g 44.
|t Pathophysiology of Chronic Pancreatitis /
|r Subhash C. Gumber and Steven D. Freedman --
|g 45.
|t Chronic Pancreatitis: Pathophysiology and Treatment of Steatorrhea /
|r Daisuke Koike and Eugene P. DiMagno --
|g 46.
|t Chronic Pancreatitis: Pathophysiology and Treatment of Pain /
|r Amy Kusske and Howard A. Reber --
|g 47.
|t The Pharmacology of Vasoconstriction /
|r Eugene D. Jacobson --
|g 48.
|t The Medical Therapy of Intestinal Ischemia /
|r Joel S. Levine --
|g 49.
|t Nausea and Vomiting /
|r Richard W. McCallum --
|g 50.
|t Use of Gastrointestinal and Hepatic Drugs During Pregnancy and Lactation /
|r Rajeev Nayar and James H. Lewis --
|g 51.
|t Gastrointestinal Cancer /
|r Lynn H. Ratner and Steven Gruenstein --
|g 52.
|t Pediatric Concerns /
|r Keith J. Benkov --
|g 53.
|t Considerations in the Geriatric Patient /
|r Lidia Pousada and Lawrence J. Brandt --
|g 54.
|t Genetics and Gene Therapy for Gastrointestinal Diseases /
|r Jayanta Roy Chowdhury, Namita Roy Chowdhury and George Y. Wu --
|g 55.
|t The Drug Development Process: An FDA Perspective /
|r Robert Temple --
|g 56.
|t Role of the Pharmaceutical Industry in Drug Development /
|r Robert H. Palmer and Leanne C. Wagner --
|g 57.
|t The Clinical Trials Process /
|r Thomas Q. Garvey III and Larry R. Muenz --
|g 58.
|t Development of Gastrointestinal Drugs for Over-the-Counter Indications /
|r Mark A. Sirgo and Bernard Schachtel --
|g 59.
|t The Economics of Drug Therapy /
|r Rulph O. Bischof, David B. Nash and James H. Lewis.
|
650 |
|
0 |
|a Gastrointestinal agents.
|0 http://id.loc.gov/authorities/subjects/sh85053482
|
650 |
|
0 |
|a Gastrointestinal system
|x Diseases
|x Treatment.
|
650 |
1 |
2 |
|a Digestive System Diseases
|x drug therapy.
|
650 |
2 |
2 |
|a Digestive System Diseases
|x physiopathology.
|
650 |
|
7 |
|a Gastrointestinal agents.
|2 fast
|0 http://id.worldcat.org/fast/fst00938855
|
650 |
|
7 |
|a Gastrointestinal system
|x Diseases
|x Treatment.
|2 fast
|0 http://id.worldcat.org/fast/fst00938882
|
700 |
1 |
|
|a Friedman, Gerald.
|0 http://id.loc.gov/authorities/names/n96802712
|1 http://viaf.org/viaf/268783663
|
700 |
1 |
|
|a Jacobson, Eugene D.
|0 http://id.loc.gov/authorities/names/n78092859
|1 http://viaf.org/viaf/161909126
|
700 |
1 |
|
|a McCallum, Richard W.
|0 http://id.loc.gov/authorities/names/n88091468
|1 http://viaf.org/viaf/51737192
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
035 |
|
|
|a (OCoLC)35599314
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 82296131-40cc-564b-9929-4f94f7d51c3d
|s 9de475e5-1412-535e-8a9a-67eccdfec328
|
928 |
|
|
|t Library of Congress classification
|a RM355 .G36 1997
|l ASR
|c ASR-SciASR
|i 4088369
|
927 |
|
|
|t Library of Congress classification
|a RM355 .G36 1997
|l ASR
|c ASR-SciASR
|e BILL
|e CRERAR
|b 50262221
|i 6195551
|